These compounds are resistant to hydrolysis by various bacterial i3-lactamases. This resistance character also provides the antibiotic with a broad antibacterial spectrum, including activity against indole-positive Proteus strains, Serratia spp. and Bacteroides spp. (including B. fragilis and all its subspecies) as well as against all the bacterial pathogens normally sensitive to the cephalosporins. There is great interest in antibiotics that are resistant to (3-lactamase hydrolysis and in compounds that are inhibitors of (:-lactamases3, 4, 5) . CFX and CMZ, cephamycin antibiotics, have been reported to be potent competitive inhibitors of some (3-lactamases6,7). We wished to assess the (3-lactamase-inhibiting activity of the compounds of the cephamycin family.
We have investigated the chromosomallymediated jS-lactamase-inhibiting activity of CFX, CMZ, YM09330 and 6059-S by determining the inhibitor constant (Ki) with cephalothin (CET) as a substrate. The plasmid-mediated penicillinase-inhibiting activity of CFX, CMZ, YM-09330 and 6059-S was investigated by determining the Ki with cephaloridine (CER) as a substrate. The maximal rate of reaction (Vmax) and the dissociation constant (Km) were derived from a LINEWEAVER-BURK plot by standard procedures. The minimal inhibitory concentrations (MICs) of the strains were determined by an agar dilution technique.
For the Enterobacteriaceae and Pseudomonas strains, the test medium was MUELLER-HINTON agar (Nissui Pharm. Co., Ltd.). For B. fragilis, the test medium was GAM agar (Nissui Pharm. Co., Ltd.). Plates were inoculated with one loopful of 106 colony-forming units (CFU) per ml. Anaerobic incubation was for 18 hours at 37°C in a Gas-Pak jar. Chromosomally-mediated (3-lactamases were extracted and purified from Escherichia coil GN5482, Enterobacter cloacae GN7471, Citrobacter freundii GN7391, S. marcescens GN10857, P. aeruginosa GN10362, P. rettgeri GN4430, P. morganii GN5407, P. vulgaris GN7919, P. cepacia GN 11164 and B. fragilis GN11477. Plasmid-mediated penicillinase type I (Rms212), type II (Rms213) and type III (Rte16)8,9,10) were extracted and purified from the transconjugants of these plasmids in E. coli W3630. Plasmid-mediated penicillinase type IV (Rms139)11) was extracted and purified from the transconjugant of this plasmid in P. aeruginosa MI. Purified (3-lactamases prepared by previously published methods7, 11, 12) were used in some experiments. (3-Lactamase assay was done by the spectrophotometric me- thod, as described previously13, 14) . Table 1 shows the susceptibility of /3-lactamaseproducing organisms to CET, ampicillin (APC), CFX, CMZ, YM09330 and 6059-S in terms of their MIC. CFX, CMZ, YM09330 and 6059-S inhibited those bacteria which were resistant to CET and APC as a result of /3-lactamase instability. No significant hydrolysis of cephamycin antibiotics could be detected by the spectrophotometric assay.
The Ki values of CFX, CMZ, YM09330 and 6059-S for inhibition of hydrolysis of CET or CER by various ,3-lactamases are shown in Table  2 . CFX, CMZ and YM09330 had a high affinity for the purified enzymes from E. coli, E. cloacae, C. freundii S. marcescens, P. aeruginosa, P. rettgeri, P. morganii and B. fragilis, as indicated by their low Ki values, and were powerful inhibitors of the action of the enzyme, although CFX, CMZ and YM09330 were less effective inhibitors of the enzyme from P. vulgaris than they were of the enzymes from the above organisms. 6059-S also had a high affinity to the purified enzymes from E. coil, E. cloacae, C. freundii, P. aeruginosa, P. morganii and B. fragilis, but the Ki values of this compound for the I3-lactamases from S. marcescens, P. rettgeri and P. vulgaris were higher than those of CFX, CMZ and YM09330. The Ki values of 6059-S for the enzymes from S. marcescens, P. rettgeri and P. vulgaris were 13.0, 102 and 107 pm, respectively. KURLYAMA and coworkers7) reported that CFX and CMZ were potent competitive inhibitors of the purified (3-lactamase from P. morganii. DARLAND and BIRNBAUM6) also reported that CFX was not a substrate for the enzyme from B. fragilis and was an excellent competitive inhibitor. In our investigation, newly introduced cephamycins such as YM09330 and 6059-S also exhibited orders of inhibitory activity in a competitive manner as high as CFX and CMZ against E. coli, E. cloacae, C. freuudii, S. marcescens, P. aeruginosa, P. rettgeri, P. morganii, P. vulgaris and B. fragilis. However, 6059-S was somewhat different from CFX, CMZ and YM09330 in the case of S. inarcescens, P. rettgeri and P. vulgaris. On the other hand, Nlactamases purified from P. cepacia and plasmidmediated penicillinase types I and IV were not inhibited by CFX, CMZ, YM09330 and 6059-S. In the case of plasmid-mediated penicillinase type 11, the Ki values for CFX, CMZ, YM09330 and 6059-S were approximately 245, 116, 8.53 and 16.7 pM, respectively. In the case of plasmidmediated penicillinase type III, the Ki values for CFX, CMZ, YM09330 and 6059-S were approximately 16.7, 2.74, 1.02 and 27.8 ptvt, respectively. YM09330 was the best competitive inhibitor of penicillinase types II and III among the compounds of the cephamycin family.
In marked contrast to the cephalosporins tested (data not shown), the compounds of the cephamycin family were not hydrolyzed by the /-lactamases from various bacteria. Not only are these compounds stable in solutions containing purified /3-lactamases, but they have also been shown to be inhibitors of the enzymes except for P. cepacia /3-lactamase and plasmid-mediated penicillinase types I and IV. They are competitive inhibitors of the enzymes as well. Studies in our laboratory have also proved that clavulanic acid (CVA) and CP-45899 were effective inhibitors of P. vulgaris, P. cepacia and B. fragilis cephalosporinase and plasmid-mediated penicillinase types I, II, III and IV (unpublished data). However, cephalosporinases from E. coil, E. cloacae, C. freundii, S. marcescens, P. aeruginosa, P. rettgeri and P. morganii were not inhibited by CVA and CP-45899. On the other hand, certain /3-lactamases of Gram-negative bacilli are inhibited by l3-lactam antibiotics such as cloxacillin or methicillin5). The degree of inhibition has therefore been used in the classification of i3-lactamases15). In this investigation, cephamycin antibiotics were found to possess not only antibacterial activity against 13-lactamase-producing organisms, but also inhibitory activity against a number of types of j:-lactamases. The inhibitory activity of cephamycin antibiotics might contribute to the characterization of j3-lactamases. 
